Subarachnoid Hemorrhage
- 1 November 2024
- journal article
- editorial
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 23 (11) , 1295-1296
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacotherapy in SAH: Clinical Trial LessonsCNS & Neurological Disorders - Drug Targets, 2024
- GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the LiteratureCNS & Neurological Disorders - Drug Targets, 2024
- Vasospasm in Pediatric Subarachnoid HemorrhageCNS & Neurological Disorders - Drug Targets, 2024
- The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping ReviewCNS & Neurological Disorders - Drug Targets, 2024
- Flow Diversion for the Management of Posterior Circulation’s Intracranial AneurysmsCNS & Neurological Disorders - Drug Targets, 2024
- Diagnosis and management of subarachnoid haemorrhageNature Communications, 2024
- Delayed Cerebral Ischemia after Subarachnoid HemorrhageJournal of Stroke and Cerebrovascular Diseases, 2021
- Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the PopulationJAMA Neurology, 2019